Immucell Stock Forecast

Buy or Hold candidate since Apr 09, 2026 Gain 35.54%

The ImmuCell Corporation stock price gained 2.69% on the last trading day (Monday, 22nd Jun 2026), rising from $9.49 to $9.75. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.36% from a day low at $9.53 to a day high of $9.85. The price has risen in 6 of the last 10 days and is up by 1.4% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 24 thousand more shares were traded than the day before. In total, 59 thousand shares were bought and sold for approximately $571.50 thousand.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $9.52 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 53.23% during the next 3 months and, with a 90% probability hold a price between $14.58 and $18.00 at the end of this 3-month period.

ICCC Signals & Forecast

The ImmuCell Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $9.56 and $9.44. A breakdown below any of these levels will issue sell signals. ImmuCell Corporation has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 27, 2026, and so far it has fallen -8.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The stock had a Golden Star Signal on Thursday, April 02, 2026 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for ImmuCell Corporation stock

On the downside, the stock finds support just below today's level from accumulated volume at $8.92 and $8.66. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ImmuCell Corporation finds support just below today's level at $8.92. If this is broken, then the next support from accumulated volume will be at $8.66 and $7.73.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.320 between high and low, or 3.36%. For the last week, the stock has had daily average volatility of 2.87%.

Our recommended stop-loss: $9.31 (-4.46%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 17 days ago.)

Trading Expectations (ICCC) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect ImmuCell Corporation to open at $9.71, and during the day (based on 14 day Average True Range), to move between $9.55 and $9.94, which gives a possible trading interval of +/-$0.400 (+/-4.19%) up or down from last closing price. If ImmuCell Corporation takes out the full calculated possible swing range there will be an estimated 4.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.79 (0.46%) than the support at $8.92 (8.47%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is ImmuCell Corporation stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ImmuCell Corporation stock to perform well in the short-term.

Current score: 4.106 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $9.71 ( 0.376%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk